Monogram Biosciences Announces Several Presentations to Be Made on HERmark(R) Breast Cancer Assay and VeraTag(TM) Technology at the 45th American Society of Clinical Oncology Meeting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Monogram Biosciences, Inc. (Nasdaq:MGRM) today announced that three presentations related to the HERmark® Breast Cancer Assay and VeraTag™ technology will be made at the 45th meeting of the American Society for Clinical Oncology (ASCO) in Orlando.